Clinical Trial Update: Study to Evaluate the Effectivity and Safety of BIOSCAFF®H Compared to DuraGen®, in Patients Undergoing Dural Repair

View source ↗

Summary

A terminated study evaluating the effectiveness and safety of BIOSCAFF®H compared to DuraGen® in dural repair for cerebrospinal fluid leakage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebrospinal Fluid Leakage

Drugs mentioned

• BIOSCAFF®H
• DuraGen®

Snippet

Sponsor: Top Health S.A.P.I DE C.V. | Conditions: Cerebrospinal Fluid Leakage | Status: TERMINATED